[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

China Lung Cancer Diagnostic Tests Market Research Report 2017

December 2017 | 105 pages | ID: C7B69CAE84EEN
QYResearch

US$ 3,400.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Lung Cancer Diagnostic Tests market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Lung Cancer Diagnostic Tests development status and future trend in China, focuses on top players in China, also splits Lung Cancer Diagnostic Tests by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include
  • Advpharma Inc
  • AIT Austrian Institute of Technology GmbH
  • Courtagen Life Sciences Inc
  • DiagnoCure Inc. (Inactive)
  • BioMark Diagnostics Inc.
  • BioMarker Strategies LLC
  • Emory University
  • Epigenomics AG
  • GlycoZym
  • HalioDx SAS
  • Louisville Bioscience, Inc.
  • Mayo Clinic US

Geographically, this report splits the China market into six regions,
  • South China
  • East China
  • Southwest China
  • Northeast China
  • North China
  • Central China
  • Northwest China
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
  • Immunoassays
  • Flow Cytometry
  • Rapid Tests
  • Molecular Assays
  • Tissue Arrays
  • Circulating Tumor Cells
  • Pharmacodiagnostics
  • Biomarkers
  • Other Diagnostics Methods
On the basis of the end users/application, this report covers
  • Precision Medicine
  • Personalized Medicine
  • Cancer Monitoring
If you have any special requirements, please let us know and we will offer you the report as you want.
China Lung Cancer Diagnostic Tests Market Research Report 2017

1 LUNG CANCER DIAGNOSTIC TESTS OVERVIEW

1.1 Product Overview and Scope of Lung Cancer Diagnostic Tests
1.2 Classification of Lung Cancer Diagnostic Tests by Product Category
  1.2.1 China Lung Cancer Diagnostic Tests Sales (K Units) Comparison by Type (2012-2022)
  1.2.2 China Lung Cancer Diagnostic Tests Sales (K Units) Market Share by Type in 2016
  1.2.3 Immunoassays
  1.2.4 Flow Cytometry
  1.2.5 Rapid Tests
  1.2.6 Molecular Assays
  1.2.7 Tissue Arrays
  1.2.8 Circulating Tumor Cells
  1.2.9 Pharmacodiagnostics
  1.2.10 Biomarkers
  1.2.11 Other Diagnostics Methods
1.3 China Lung Cancer Diagnostic Tests Market by Application/End Users
  1.3.1 China Lung Cancer Diagnostic Tests Sales (K Units) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Precision Medicine
  1.3.3 Personalized Medicine
  1.3.4 Cancer Monitoring
1.4 China Lung Cancer Diagnostic Tests Market by Region
  1.4.1 China Lung Cancer Diagnostic Tests Market Size (Million USD) Comparison by Region (2012-2022)
  1.4.2 South China Lung Cancer Diagnostic Tests Status and Prospect (2012-2022)
  1.4.3 East China Lung Cancer Diagnostic Tests Status and Prospect (2012-2022)
  1.4.4 Southwest China Lung Cancer Diagnostic Tests Status and Prospect (2012-2022)
  1.4.5 Northeast China Lung Cancer Diagnostic Tests Status and Prospect (2012-2022)
  1.4.6 North China Lung Cancer Diagnostic Tests Status and Prospect (2012-2022)
  1.4.7 Central China Lung Cancer Diagnostic Tests Status and Prospect (2012-2022)
1.5 China Market Size (Sales and Revenue) of Lung Cancer Diagnostic Tests (2012-2022)
  1.5.1 China Lung Cancer Diagnostic Tests Sales (K Units) and Growth Rate (%)(2012-2022)
  1.5.2 China Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 CHINA LUNG CANCER DIAGNOSTIC TESTS MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China Lung Cancer Diagnostic Tests Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2 China Lung Cancer Diagnostic Tests Revenue and Share by Players/Manufacturers (2012-2017)
2.3 China Lung Cancer Diagnostic Tests Average Price (USD/Unit) by Players/Manufacturers (2012-2017)
2.4 China Lung Cancer Diagnostic Tests Market Competitive Situation and Trends
  2.4.1 China Lung Cancer Diagnostic Tests Market Concentration Rate
  2.4.2 China Lung Cancer Diagnostic Tests Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Lung Cancer Diagnostic Tests Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA LUNG CANCER DIAGNOSTIC TESTS SALES AND REVENUE BY REGION (2012-2017)

3.1 China Lung Cancer Diagnostic Tests Sales (K Units) and Market Share by Region (2012-2017)
3.2 China Lung Cancer Diagnostic Tests Revenue (Million USD) and Market Share by Region (2012-2017)
3.3 China Lung Cancer Diagnostic Tests Price (USD/Unit) by Regions (2012-2017)

4 CHINA '&B1&' SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2012-2017)'

4.1 China Lung Cancer Diagnostic Tests Sales (K Units) and Market Share by Type/ Product Category (2012-2017)
4.2 China Lung Cancer Diagnostic Tests Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 China Lung Cancer Diagnostic Tests Price (USD/Unit) by Type (2012-2017)
4.4 China Lung Cancer Diagnostic Tests Sales Growth Rate (%) by Type (2012-2017)

5 CHINA '&B1&' SALES BY APPLICATION (2012-2017)'

5.1 China Lung Cancer Diagnostic Tests Sales (K Units) and Market Share by Application (2012-2017)
5.2 China Lung Cancer Diagnostic Tests Sales Growth Rate (%) by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 CHINA LUNG CANCER DIAGNOSTIC TESTS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Advpharma Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Advpharma Inc Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  6.1.4 Main Business/Business Overview
6.2 AIT Austrian Institute of Technology GmbH
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Courtagen Life Sciences Inc
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  6.3.4 Main Business/Business Overview
6.4 DiagnoCure Inc. (Inactive)
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  6.4.4 Main Business/Business Overview
6.5 BioMark Diagnostics Inc.
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  6.5.4 Main Business/Business Overview
6.6 BioMarker Strategies LLC
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Emory University
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Emory University Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Epigenomics AG
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Epigenomics AG Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  6.8.4 Main Business/Business Overview
6.9 GlycoZym
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 GlycoZym Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  6.9.4 Main Business/Business Overview
6.10 HalioDx SAS
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 HalioDx SAS Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Louisville Bioscience, Inc.
6.12 Mayo Clinic US

7 LUNG CANCER DIAGNOSTIC TESTS MANUFACTURING COST ANALYSIS

7.1 Lung Cancer Diagnostic Tests Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Lung Cancer Diagnostic Tests

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Lung Cancer Diagnostic Tests Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Lung Cancer Diagnostic Tests Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA LUNG CANCER DIAGNOSTIC TESTS MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

11.1 China Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
11.2 China Lung Cancer Diagnostic Tests Sales (K Units) Forecast by Type (2017-2022)
11.3 China Lung Cancer Diagnostic Tests Sales (K Units) Forecast by Application (2017-2022)
11.4 China Lung Cancer Diagnostic Tests Sales (K Units) Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Global and China Market Size (Million USD) Comparison (2012-2022)
Table Lung Cancer Diagnostic Tests Sales (K Units) and Revenue (Million USD) Market Split by Product Type
Table Lung Cancer Diagnostic Tests Sales (K Units) by Application (2016-2022)
Figure Product Picture of Lung Cancer Diagnostic Tests
Table China Lung Cancer Diagnostic Tests Sales (K Units) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure China Lung Cancer Diagnostic Tests Sales Volume Market Share by Types in 2016
Figure Immunoassays Product Picture
Figure Flow Cytometry Product Picture
Figure Rapid Tests Product Picture
Figure Molecular Assays Product Picture
Figure Tissue Arrays Product Picture
Figure Circulating Tumor Cells Product Picture
Figure Pharmacodiagnostics Product Picture
Figure Biomarkers Product Picture
Figure Other Diagnostics Methods Product Picture
Figure China Lung Cancer Diagnostic Tests Sales (K Units) Comparison by Application (2012-2022)
Figure China Sales Market Share (%) of Lung Cancer Diagnostic Tests by Application in 2016
Figure Precision Medicine Examples
Table Key Downstream Customer in Precision Medicine
Figure Personalized Medicine Examples
Table Key Downstream Customer in Personalized Medicine
Figure Cancer Monitoring Examples
Table Key Downstream Customer in Cancer Monitoring
Figure South China Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (2012-2022)
Figure East China Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest China Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (2012-2022)
Figure Northeast China Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (2012-2022)
Figure North China Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (2012-2022)
Figure Central China Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Lung Cancer Diagnostic Tests Sales (K Units) and Growth Rate (%)(2012-2022)
Figure China Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (%)(2012-2022)
Table China Lung Cancer Diagnostic Tests Sales of Key Players/Manufacturers (2012-2017)
Table China Lung Cancer Diagnostic Tests Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Lung Cancer Diagnostic Tests Sales Share (%) by Players/Manufacturers
Figure 2017 China Lung Cancer Diagnostic Tests Sales Share (%) by Players/Manufacturers
Table China Lung Cancer Diagnostic Tests Revenue by Players/Manufacturers (2012-2017)
Table China Lung Cancer Diagnostic Tests Revenue Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Lung Cancer Diagnostic Tests Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Lung Cancer Diagnostic Tests Revenue Market Share (%) by Players/Manufacturers
Table China Market Lung Cancer Diagnostic Tests Average Price of Key Players/Manufacturers (2012-2017)
Figure China Market Lung Cancer Diagnostic Tests Average Price of Key Players/Manufacturers in 2016
Figure China Lung Cancer Diagnostic Tests Market Share of Top 3 Players/Manufacturers
Figure China Lung Cancer Diagnostic Tests Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Lung Cancer Diagnostic Tests Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Lung Cancer Diagnostic Tests Product Category
Table China Lung Cancer Diagnostic Tests Sales (K Units) by Regions (2012-2017)
Table China Lung Cancer Diagnostic Tests Sales Share (%) by Regions (2012-2017)
Figure China Lung Cancer Diagnostic Tests Sales Share (%) by Regions (2012-2017)
Figure China Lung Cancer Diagnostic Tests Sales Market Share (%) by Regions in 2016
Table China Lung Cancer Diagnostic Tests Revenue (Million USD) and Market Share by Regions (2012-2017)
Table China Lung Cancer Diagnostic Tests Revenue Market Share (%) by Regions (2012-2017)
Figure China Lung Cancer Diagnostic Tests Revenue Market Share (%) by Regions (2012-2017)
Figure China Lung Cancer Diagnostic Tests Revenue Market Share (%) by Regions in 2016
Table China Lung Cancer Diagnostic Tests Price (USD/Unit) by Regions (2012-2017)
Table China Lung Cancer Diagnostic Tests Sales (K Units) by Type (2012-2017)
Table China Lung Cancer Diagnostic Tests Sales Share (%) by Type (2012-2017)
Figure China Lung Cancer Diagnostic Tests Sales Share (%) by Type (2012-2017)
Figure China Lung Cancer Diagnostic Tests Sales Market Share (%) by Type in 2016
Table China Lung Cancer Diagnostic Tests Revenue (Million USD) and Market Share by Type (2012-2017)
Table China Lung Cancer Diagnostic Tests Revenue Market Share (%) by Type (2012-2017)
Figure Revenue Market Share of Lung Cancer Diagnostic Tests by Type (2012-2017)
Figure Revenue Market Share of Lung Cancer Diagnostic Tests by Type in 2016
Table China Lung Cancer Diagnostic Tests Price (USD/Unit) by Types (2012-2017)
Figure China Lung Cancer Diagnostic Tests Sales Growth Rate (%) by Type (2012-2017)
Table China Lung Cancer Diagnostic Tests Sales (K Units) by Applications (2012-2017)
Table China Lung Cancer Diagnostic Tests Sales Market Share (%) by Applications (2012-2017)
Figure China Lung Cancer Diagnostic Tests Sales Market Share (%) by Application (2012-2017)
Figure China Lung Cancer Diagnostic Tests Sales Market Share (%) by Application in 2016
Table China Lung Cancer Diagnostic Tests Sales Growth Rate (%) by Application (2012-2017)
Figure China Lung Cancer Diagnostic Tests Sales Growth Rate (%) by Application (2012-2017)
Table Advpharma Inc Lung Cancer Diagnostic Tests Basic Information List
Table Advpharma Inc Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Advpharma Inc Lung Cancer Diagnostic Tests Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Advpharma Inc Lung Cancer Diagnostic Tests Sales Market Share (%) in China (2012-2017)
Figure Advpharma Inc Lung Cancer Diagnostic Tests Revenue Market Share (%) in China (2012-2017)
Table AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Basic Information List
Table AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Sales (K Units) and Growth Rate (%)(2012-2017)
Figure AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Sales Market Share (%) in China (2012-2017)
Figure AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Revenue Market Share (%) in China (2012-2017)
Table Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Basic Information List
Table Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Sales Market Share (%) in China (2012-2017)
Figure Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Revenue Market Share (%) in China (2012-2017)
Table DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Basic Information List
Table DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Sales (K Units) and Growth Rate (%)(2012-2017)
Figure DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Sales Market Share (%) in China (2012-2017)
Figure DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Revenue Market Share (%) in China (2012-2017)
Table BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Basic Information List
Table BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Sales (K Units) and Growth Rate (%)(2012-2017)
Figure BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Sales Market Share (%) in China (2012-2017)
Figure BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Revenue Market Share (%) in China (2012-2017)
Table BioMarker Strategies LLC Lung Cancer Diagnostic Tests Basic Information List
Table BioMarker Strategies LLC Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure BioMarker Strategies LLC Lung Cancer Diagnostic Tests Sales (K Units) and Growth Rate (%)(2012-2017)
Figure BioMarker Strategies LLC Lung Cancer Diagnostic Tests Sales Market Share (%) in China (2012-2017)
Figure BioMarker Strategies LLC Lung Cancer Diagnostic Tests Revenue Market Share (%) in China (2012-2017)
Table Emory University Lung Cancer Diagnostic Tests Basic Information List
Table Emory University Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Emory University Lung Cancer Diagnostic Tests Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Emory University Lung Cancer Diagnostic Tests Sales Market Share (%) in China (2012-2017)
Figure Emory University Lung Cancer Diagnostic Tests Revenue Market Share (%) in China (2012-2017)
Table Epigenomics AG Lung Cancer Diagnostic Tests Basic Information List
Table Epigenomics AG Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Epigenomics AG Lung Cancer Diagnostic Tests Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Epigenomics AG Lung Cancer Diagnostic Tests Sales Market Share (%) in China (2012-2017)
Figure Epigenomics AG Lung Cancer Diagnostic Tests Revenue Market Share (%) in China (2012-2017)
Table GlycoZym Lung Cancer Diagnostic Tests Basic Information List
Table GlycoZym Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure GlycoZym Lung Cancer Diagnostic Tests Sales (K Units) and Growth Rate (%)(2012-2017)
Figure GlycoZym Lung Cancer Diagnostic Tests Sales Market Share (%) in China (2012-2017)
Figure GlycoZym Lung Cancer Diagnostic Tests Revenue Market Share (%) in China (2012-2017)
Table HalioDx SAS Lung Cancer Diagnostic Tests Basic Information List
Table HalioDx SAS Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure HalioDx SAS Lung Cancer Diagnostic Tests Sales (K Units) and Growth Rate (%)(2012-2017)
Figure HalioDx SAS Lung Cancer Diagnostic Tests Sales Market Share (%) in China (2012-2017)
Figure HalioDx SAS Lung Cancer Diagnostic Tests Revenue Market Share (%) in China (2012-2017)
Table Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Basic Information List
Table Mayo Clinic US Lung Cancer Diagnostic Tests Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Lung Cancer Diagnostic Tests
Figure Manufacturing Process Analysis of Lung Cancer Diagnostic Tests
Figure Lung Cancer Diagnostic Tests Industrial Chain Analysis
Table Raw Materials Sources of Lung Cancer Diagnostic Tests Major Players/Manufacturers in 2016
Table Major Buyers of Lung Cancer Diagnostic Tests
Table Distributors/Traders List
Figure China Lung Cancer Diagnostic Tests Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure China Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Lung Cancer Diagnostic Tests Price (USD/Unit) Trend Forecast (2017-2022)
Table China Lung Cancer Diagnostic Tests Sales (K Units) Forecast by Type (2017-2022)
Figure China Lung Cancer Diagnostic Tests Sales (K Units) Forecast by Type (2017-2022)
Figure China Lung Cancer Diagnostic Tests Sales Volume Market Share Forecast by Type in 2022
Table China Lung Cancer Diagnostic Tests Sales (K Units) Forecast by Application (2017-2022)
Figure China Lung Cancer Diagnostic Tests Sales Volume Market Share Forecast by Application (2017-2022)
Figure China Lung Cancer Diagnostic Tests Sales Volume Market Share Forecast by Application in 2022
Table China Lung Cancer Diagnostic Tests Sales (K Units) Forecast by Regions (2017-2022)
Table China Lung Cancer Diagnostic Tests Sales Volume Share Forecast by Regions (2017-2022)
Figure China Lung Cancer Diagnostic Tests Sales Volume Share Forecast by Regions (2017-2022)
Figure China Lung Cancer Diagnostic Tests Sales Volume Share Forecast by Regions in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories